Related Experiment Video
Updated: Jun 22, 2026
10:09
A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)
Published on: March 15, 2017
Glucosinolate engineering identifies a gamma-glutamyl peptidase.
Fernando Geu-Flores1, Morten Thrane Nielsen, Majse Nafisi
1Plant Biochemistry Laboratory, Department of Plant Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.
Nature Chemical Biology
|June 2, 2009
Summary
Researchers engineered noncruciferous plants to produce benzylglucosinolate, a compound found in cruciferous vegetables linked to cancer risk reduction. A newly identified enzyme, gamma-glutamyl peptidase 1 (GGP1), significantly boosted this production.
Area of Science:
- Plant biotechnology
- Metabolic engineering
- Biochemistry
Background:
- Cruciferous vegetables contain glucosinolates, compounds associated with reduced cancer risk.
- The biosynthesis of glucosinolates and their role in plant defense and human health are areas of active research.
- Genetic modification offers a pathway to produce valuable plant compounds in alternative hosts.
Purpose of the Study:
- To engineer the production of bioactive benzylglucosinolate in a noncruciferous plant, Nicotiana benthamiana.
- To identify factors limiting glucosinolate accumulation in engineered plants.
- To characterize novel enzymatic activities involved in glucosinolate biosynthesis.
Main Methods:
- Metabolic engineering of Nicotiana benthamiana to introduce the benzylglucosinolate biosynthetic pathway.
- Identification and characterization of plant enzymes involved in intermediate metabolite processing.
- Enzyme assays and metabolite analysis to quantify glucosinolate production and intermediate accumulation.
Main Results:
- Successful production of benzylglucosinolate in Nicotiana benthamiana.
- Identification of gamma-glutamyl peptidase 1 (GGP1) as a key enzyme.
- GGP1 was found to metabolize a glutathione conjugate, significantly enhancing glucosinolate yield.
- This GGP1 activity represents a novel function in glucosinolate biosynthesis.
Conclusions:
- Metabolic engineering can enable the production of valuable glucosinolates in non-traditional plant hosts.
- The enzyme GGP1 plays a critical, previously unrecognized role in optimizing glucosinolate biosynthesis.
- This work opens avenues for enhanced production of bioactive compounds through understanding novel enzymatic functions.
More Related Videos
Related Concept Videos
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:24Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
01:24Tagging and Fusion Proteins
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...